Healthequity, Inc.
HQY- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001428336
In the last 90 days, Healthequity, Inc. insiders filed 0 open-market purchases and 3 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $8.10B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.26M in total
- 3
- 13F holdersQ2 2026, +21 vs. previous quarter
- 500
- 13F valueReported value at the end of Q2 2026
- $8.10B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HQY, Q2 2026
No superinvestor reported holding HQY at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Healthequity, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 (view filing)5:04 PM ET | Aug 25 | 2 days | Dillon Adrian TDirector | SSale | −7.63K | $104.61 | −$798.4K | −10.9%62.4K after | 2 lots10b5-1 |
| Jul 14, 2026 (view filing)4:23 PM ET | Jul 10 | 4 days | Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER | SSale | −2.35K | $95.00 | −$223.6K | −4.3%52.2K after | 10b5-1 |
| Jul 7, 2026 (view filing)4:36 PM ET | Jul 2 | 5 days | Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER | SSale | −2.47K | $95.00 | −$234.7K | −4.2%56.6K after | 10b5-1 |
| Jun 2, 2026 (view filing) | May 29 | 4 days | Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER | SSale | −3.14K | $95.00 | −$298.5K | −5.0%59.1K after | 10b5-1 |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Wellborn Gayle FurgursonDirector | SSale | −2.44K | $90.00 | −$219.5K | −11.0%19.7K after | 10b5-1 |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Ladd DelanoEVP, General Counsel | SSale | −7.50K | $90.00 | −$675.0K | −7.6%91.1K after | 10b5-1 |
| Dec 23, 2025 (view filing) | Dec 19 | 4 days | Ladd DelanoEVP, General Counsel | SSale | −1.50K | $94.72 | −$142.1K | −2.0%74.0K after | 10b5-1 |
| Dec 19, 2025 (view filing) | Dec 18 | 1 day | Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER | SSale | −11.0K | $95.45 | −$1.05M | −19.3%45.7K after | |
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Wellborn Gayle FurgursonDirector | SSale | −4.34K | $98.03 | −$425.4K | −18.0%19.7K after | |
| Nov 24, 2025 (view filing) | Nov 20 | 4 days | Ladd DelanoEVP, General Counsel | SSale | −1.50K | $104.56 | −$156.8K | −1.9%75.5K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Healthequity, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,277,914 | $1.02B | 0.02% | +745,520+7.1% | Added |
| Wasatch Advisors Inc | 7,960,735 | $719.0M | 4.71% | +757,801+10.5% | Added |
| Morgan Stanley | 4,547,219 | $410.7M | 0.02% | +2,061,306+82.9% | Added |
| Vanguard Portfolio Management LLC | 4,057,643 | $366.5M | 0.02% | −105,950−2.5% | Reduced |
| Vanguard Capital Management LLC | 3,640,776 | $328.8M | 0.01% | −183,028−4.8% | Reduced |
| State Street Corp | 3,241,046 | $292.7M | 0.01% | +141,149+4.6% | Added |
| Geode Capital Management, LLC | 2,374,467 | $214.5M | 0.01% | +114,821+5.1% | Added |
| AQR Capital Management LLC | 1,999,209 | $176.1M | 0.06% | −93,014−4.4% | Reduced |
| Dimensional Fund Advisors LP | 1,869,036 | $168.8M | 0.03% | +241,997+14.9% | Added |
| William Blair Investment Management, LLC | 1,773,227 | $160.2M | 0.48% | +113,611+6.8% | Added |